O2 Trials Femotcells with NEC and Ubiquisys

Telefónica O2 Europe today announced live femtocell experience trials in the UK in partnership with NEC Corporation and Ubiquisys, targeting a commercial launch of the technology by early 2009.

The UK’s first full trial of femtocell technology – which is a new way of improving in-building 3G coverage – has begun an initial period of live testing in February. If successful, the trial will be rolled out in greater numbers across the UK in the summer.

NEC – a leading provider of 3G infrastructure and handsets, internet and broadband network solutions – is O2’s trial partner and has supplied an integrated solution centred around Ubiquisys ZoneGate femtocells.

Vivek Dev, Chief Operating Officer of Telefónica O2 Europe, said: “This technology has the potential to support increased growth in the usage and consumption of services and data and could play a crucial role in underpinning the explosive growth of mobile broadband usage.”

Rating: it’s in the femtocell

Related News:

1. T-Mobile Venture Fund invests in Ubiquisys
2. NEC Strengthens PASOLINK’s Ultra-Compact Microwave Communication Business in Eastern Europe
3. TELEFÓNICA ANNOUNCES GLOBAL MOBILE ADVERTISING ALLIANCE
4. NEC Secures WiMAX Forum® Certification for Base Stations and 2.5GHz Mobile Subscriber Units
5. NEC and Bubble Motion Announce Global Partnership